Shares of Novan (NOVN) stock has surged 10% on the company getting granted patent on Nitric Oxide Releasing Compositions in Europe.
This most likely is connecting to their inhalent drug for COVID-19.
Shares of Novan (NOVN) stock has surged 10% on the company getting granted patent on Nitric Oxide Releasing Compositions in Europe.
This most likely is connecting to their inhalent drug for COVID-19.